What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill

For income investors, the key takeaway is to prioritize dividend reliability over merely high yield, as exemplified by Pfizer's 7.2% yield, which is tempered by its history of dividend cuts and current industry headwinds. The article advocates for stocks like Johnson & Johnson (3% yield, a Dividend King with 60+ years of increases), Omega Healthcare (6.4% yield, maintained dividend through the pandemic and showing recent FFO growth), and Merck (4% yield, strong historical dividend support) due to their proven consistency in payouts. This underscores that a track record of dividend resilience, particularly during challenging periods, is a more critical factor for secure income generation than the current yield percentage alone.

Analysis

The analysis prioritizes dividend reliability over headline yield for income-oriented investors, using the healthcare sector as a case study. Pfizer (PFE), despite its high 7.2% yield, is presented as a cautionary example due to its history of cutting its dividend in 2009 to fund the Wyeth acquisition and current headwinds from downbeat vaccine sentiment. In contrast, three alternatives are highlighted for their superior dividend consistency. Merck (MRK), with a 4% yield, is favored for its long history of supporting its dividend through difficult periods, making it a more reliable pharmaceutical peer. Omega Healthcare (OHI), a senior housing REIT with a nearly 6.4% yield, is noted for its resilience in maintaining its dividend throughout the COVID-19 pandemic, a period where competitors faltered; its security is further supported by a recent 8% year-over-year increase in adjusted funds from operations (FFO). Finally, Johnson & Johnson (JNJ) is positioned as the benchmark for safety, being a 'Dividend King' with over 60 consecutive years of dividend increases. While its 3% yield is the lowest of the group, it remains above the 1.7% healthcare sector average, offering premium reliability despite facing industry-wide risks and specific litigation challenges.

Key Decisions for Investors

• Income-focused investors should prioritize demonstrated dividend reliability and a history of consistent payouts over high-yield stocks like Pfizer, which has a record of cutting dividends for strategic purposes.
• For a balance of yield and security, Merck offers a stable pharma alternative with a 4% yield and strong payout history, while Omega Healthcare's 6.4% yield is supported by its resilience during the pandemic and an 8% YoY increase in adjusted FFO.
• Investors prioritizing maximum long-term dividend security should consider Johnson & Johnson, as its 'Dividend King' status and over 60 years of dividend growth provide a high degree of reliability, justifying its lower 3% yield.